-
Mashup Score: 28Contribution of an under-recognized adversity to child health risk: large-scale, population-based ACEs screening. - 9 day(s) ago
Background and Objectives: Whereas adverse early life experiences (ACEs) correlate with cognitive, emotional and physical health at the population level, existing ACEs screens are only weakly predictive of outcomes for an individual child. This raises the possibility that important elements of the early-life experiences that drive vulnerability and resilience are not being captured. We previously demonstrated that unpredictable parental and household signals constitute an ACE with cross-cultural relevance. We created the 5-item Questionnaire of Unpredictability in Childhood (QUIC-5) that can be readily administered in pediatric clinics. Here, we tested if combined screening with the QUIC-5 and an ACEs measure in this real-world setting significantly improved prediction of child health outcomes. Methods: Leveraging existing screening with the Pediatric ACEs and Related Life Events Screener (PEARLS) at annual well-child visits, we implemented QUIC-5 screening in 19 pediatric clinics span
Source: www.medrxiv.orgCategories: General Medicine News, NephrologyTweet
-
Mashup Score: 10Targeting Corticotropin-Releasing Hormone Receptor Type 1 (CRHR1) Neurons: Validating the Specificity of a Novel Transgenic Crhr1-FlpO Mouse - 3 month(s) ago
Introduction: Corticotropin-releasing hormone (CRH) signaling through its cognate receptors, CRHR1 and CRHR2, contributes to diverse stress-related functions in the mammalian brain. Whereas CRHR2 is predominantly expressed in choroid plexus and blood vessels, CRHR1 is abundantly expressed in neurons in discrete brain regions, including the neocortex, hippocampus and nucleus accumbens. Activation of CRHR1 influences motivated behaviors, emotional states, and learning and memory. However, it is unknown whether alterations in CRHR1 signaling contribute to aberrant motivated behaviors observed, for example, in stressful contexts. These questions require tools to manipulate CRHR1 selectively. Here we describe and validate a novel Crhr1-FlpO mouse. Methods: Using bacterial artificial chromosome (BAC) transgenesis, we engineered a transgenic mouse that expresses FlpO recombinase in CRHR1-expressing cells. We used two independent methods to assess the specificity of FlpO to CRHR1-expressing ce
Source: www.biorxiv.orgCategories: General Medicine News, NephrologyTweet-
#Stress lovers, CRH fans, #GPCR afficionados! see validated CRHR1-driven Flpo mouse that allows playing with the receptor. Made by the amazing Nick Justice @windansea23 1st 1st author paper for mason hardy https://t.co/XFlNoy9u4y & find me in brightblue @talliezee.bsky.social https://t.co/GCjArymjBG
-
Breaking silence to share our translational study in >30,000 kids. Showing unpredictable signal patterns from parents and environment are an early-life adversity and a major for depression https://t.co/CmzvEkmu3Z @dylanggee @CAPublicHealth https://t.co/eXzsGwHeT5